In a report released yesterday, Brian Meredith from UBS maintained a Buy rating on Metlife (MET – Research Report), with a price target of ...
JPMorgan lowered the firm’s price target on MetLife (MET) to $86 from $88 and keeps an Overweight rating on the shares. The firm shifted its ...
3d
Zacks Investment Research on MSNMetLife (MET) is a Top Dividend Stock Right Now: Should You Buy?Whether it's through stocks, bonds, ETFs, or other types of securities, all investors love seeing their portfolios score big returns. But when you're an income investor, your primary focus is ...
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does MetLife (MET) have what it takes? Let's find out. NEW YORK, March 26 ...
Among the 18 analysts covering the stock, the consensus rating is ... On Jan. 7, JPMorgan maintained an “Overweight” rating on MET and raised its price target to $88, which indicates a 4.9 ...
They currently have an overweight rating on the financial services provider’s stock. Several other brokerages have also issued reports on MET. Keefe, Bruyette & Woods reduced their price target ...
We recently published a list of Top 12 Extreme Value Stocks to Invest In Right Now. In this article, we are going to take a look at where MetLife, Inc. (NYSE:MET) stands against other top extreme ...
More than 100 CEOs and business leaders in New York City are calling for federal action to fix the United States' broken immigration system and address the migrant crisis.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results